Guidance Notes - Clinical Biomarkers (pdf)
Detailed guidance on applying for a Clinical Biomarkers award
Funds to identify and implement molecular testing for those affected by a brain tumour.
This scheme supports the identification of markers, validation of markers and their implementation into routine clinical use in the UK so that each patient benefits from an early and accurate diagnosis. Studies may make use of the samples and infrastructure brought about by funded clinical trials, to go beyond the primary and secondary endpoints and generate new knowledge around clinical biomarkers.
Guide costs: up to £100,000 per year for up to five years.
Funding is intended to allow the production of new insights (e.g. identification of new biomarkers or further stratification of the trial population) which will lead us to early and accurate diagnosis. This funding should be primarily allocated to cover direct costs of consumables, and additional FTE costs where appropriate justification is made. Requests for capital /infrastructure will not be considered since it is expected that this will be available at the Lead Institution as well as all partner organisations.
Grants will be awarded to the principal applicant's institution. Funding can be allocated to co-investigator institutions with agreements put in place between all partner institutions.
Applications are accepted throughout the year and must be submitted via the online portal
Applications will be considered in spring and autumn at the Scientific Advisory Board meetings.
Proposals submitted by 1 October 2017 will be considered in March 2018.
Proposals submitted by 1 April 2018 will be considered in autumn 2018.
Please read our Terms and Conditions before applying for funding.
All applications must have input from those affected by brain tumours as early as possible, preferably during scoping of the project. We strongly recommend that applicants access our Research Involvement Network (RIN) for public and patient involvement.
Expertise of applicants
Potential for patient benefit
Value for money
The Brain Tumour Charity is a member of the Association of Medical Research Charities (AMRC) and adheres to its principles of peer review. Applications will be awarded through a competitive peer reviewed process (in line with AMRC principles) and then considered by our Scientific Advisory Boards (SABs).
If you would like to discuss your application or need any information, please contact the Research Team.
Phone: +44 (0) 1252 418190